Related Experiment Video
Updated: Aug 15, 2025

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
Published on: May 19, 2023
Validation of a Deep Learning-Based Model to Predict Lung Cancer Risk Using Chest Radiographs and Electronic Medical
Vineet K Raghu1,2, Anika S Walia1, Aniket N Zinzuwadia1
1Cardiovascular Imaging Research Center, Department of Radiology, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts.
A new deep learning tool, CXR-LC, can identify high-risk individuals for lung cancer screening using existing chest X-rays and electronic health records. This approach may improve screening participation by automatically flagging eligible patients.
Area of Science:
- Oncology
- Radiology
- Artificial Intelligence
Background:
- Lung cancer screening with CT scans can reduce mortality, but participation rates are low (<5%).
- Automated identification of high-risk individuals is crucial for improving screening uptake.
- Existing electronic medical record (EMR) data and chest radiographs offer a potential resource for risk assessment.
Purpose of the Study:
- To validate the CXR-LC deep learning tool for identifying high-risk individuals for lung cancer screening.
- To compare CXR-LC performance with the 2022 US Centers for Medicare & Medicaid Services (CMS) screening guidelines.
- To assess the utility of CXR-LC in complementing existing lung cancer screening eligibility criteria.
Main Methods:
- A prognostic study compared CXR-LC risk estimates with CMS guidelines using EMR data from a large US hospital system.
- Participants included current or former smokers with chest radiographs between 2013-2014, excluding those with prior lung cancer or CT screening.
- CXR-LC inputs included chest radiograph images, age, sex, and smoking status; data analysis occurred between May 2021 and June 2022.
Main Results:
- CXR-LC identified high-risk patients, with those eligible by both CXR-LC and CMS criteria showing a significantly higher lung cancer rate (8.5%) compared to CMS alone (2.8%).
- Even when CMS eligibility was unknown (57.4% of cases), CXR-LC identified patients with a 5-fold higher lung cancer incidence.
- The tool demonstrated effectiveness across various subgroups, including female patients and Black individuals.
Conclusions:
- CXR-LC, utilizing routine chest radiographs and EMR data, effectively identifies individuals at high risk for lung cancer.
- The tool can automate the identification of patients who may benefit from lung cancer screening CT.
- CXR-LC shows promise in enhancing lung cancer screening participation and complementing current guidelines.
More Related Videos
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
07:53Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
Published on: October 13, 2023